Article metrics

other Versions

Download PDFPDF
A phase III, randomized, double blinded trial of platinum based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal, or peritoneal cancer and platinum treatment free interval of more than 6 months: ENGOT-Ov41/GEICO 69-O/ANITA Trial


Online download statistics by month:

Online download statistics by month: December 2020 to November 2021

Dec 20204213119
Jan 20212852113
Feb 20215182117
Mar 20215862413
Apr 202112603011
May 2021189149
Jun 2021735
Jul 20211153
Aug 20211178
Sep 20211138
Oct 202124045
Nov 202122662